2m 2m 2m 2m 2m 2m 2m
TRANSCODE THERA (RNAZ)
NASDAQ
$1.57+$0.03 (+1.62%)
Price as of Oct 02, 2026 4:34 PM EDT- $26.2MMarket Cap
- -85.40%1-Year Change
- BiotechnologyIndustry
TRANSCODE THERA (RNAZ)
$1.57+$0.03 (+1.62%)
RNAZ | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.54 | ||
Change | -$0.13 (-8.04%) | ||
Open | $1.67 | ||
High | $1.74 | ||
Low | $1.52 | ||
Previous Close | $1.68 | ||
Volume | 16,712 | ||
30-Day Average Volume | 51,103 | ||
1-Week Change | -6.36% | ||
1-Month Change | -25.00% | ||
1-Year Change | -85.40% | ||
3-Year Change | -99.99% | ||
5-Year Change | -100.00% | ||
Fundamentals | |||
Shares Outstanding | 16.9M | ||
Total Assets | $151.0M | ||
Market Cap | $26.2M | ||
Enterprise Value | $18.4M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$6.8M | ||
Free Cash Flow | -$5.4M | ||
EBIT | -$6.7M | ||
EBITDA | -$6.7M | ||
Net Working Capital | $5.2M | ||
EPS | -$7.17 | ||
Enterprise Value/EBITDA | -3 | ||
Enterprise Value/Revenue | N/A | ||
P/B | -1 | ||
P/E | -0 | ||
PEG | -0 | ||
Price/Free Cash Flow | -5 | ||
Price/Operating Cash Flow | -5 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 28 | ||
Last Split Date | 05/15/2025 | ||
Earnings & Revenue